Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.
暂无分享,去创建一个
Douglas L Packer | Samuel J Asirvatham | D. Packer | S. Asirvatham | D. Bradley | David J Bradley | Mark A Crandall | Mark A. Crandall
[1] Charles J Bruce,et al. Dynamic changes of left ventricular performance and left atrial volume induced by the mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure. , 2008, The American journal of cardiology.
[2] P. Vestergaard,et al. Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. , 2005, The American journal of clinical nutrition.
[3] Hakan Oral,et al. Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation , 2002, Circulation.
[4] M. Pfeffer,et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. , 2006, Journal of the American College of Cardiology.
[5] J Clémenty,et al. Radiofrequency ablation for atrial fibrillation , 2003 .
[6] O. Benavente,et al. Increased Risk of Intracranial Hemorrhage when Aspirin Is Combined with Warfarin: A Meta-Analysis and Hypothesis , 1999, Cerebrovascular Diseases.
[7] S. Connolly,et al. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. , 2005, American Heart Journal.
[8] L. Goldman,et al. Supraventricular Arrhythmia in Patients Having Noncardiac Surgery: Clinical Correlates and Effect on Length of Stay , 1998, Annals of Internal Medicine.
[9] D. Singer,et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. , 1996, The New England journal of medicine.
[10] Is Atrial Fibrillation a Genetic Disease , 2004 .
[11] Peng-Sheng Chen,et al. Autonomic nerve activity and atrial fibrillation. , 2007, Heart rhythm.
[12] J. Halperin,et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. , 2001, The New England journal of medicine.
[13] R B D'Agostino,et al. Stroke severity in atrial fibrillation. The Framingham Study. , 1996, Stroke.
[14] G. Lip,et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. , 2008, Journal of the American College of Cardiology.
[15] W. Manning,et al. Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. , 1995, Circulation.
[16] B. Knight,et al. Electrical and pharmacologic cardioversion for atrial fibrillation. , 2008, The Medical clinics of North America.
[17] E. Hylek,et al. Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin , 1994, Annals of Internal Medicine.
[18] P. Wolf,et al. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. , 1985, JAMA.
[19] J. Thomas,et al. Left atrial appendage "stunning" after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography. , 1995, American heart journal.
[20] J. W. Kinch,et al. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies. , 1995, Archives of internal medicine.
[21] M. Earley,et al. Catheter ablation of permanent atrial fibrillation: medium term results , 2005, Heart.
[22] Mandeep Bhargava,et al. Pulmonary Vein Stenosis After Radiofrequency Ablation of Atrial Fibrillation: Functional Characterization, Evolution, and Influence of the Ablation Strategy , 2003, Circulation.
[23] H. Nathan,et al. The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. , 1966, Circulation.
[24] P. Schweitzer,et al. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis. , 1998, The American journal of cardiology.
[25] M. Pfeffer,et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial , 2006, The Lancet.
[26] W. Lehmacher,et al. Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial , 2004, Circulation.
[27] Palle Petersen,et al. PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.
[28] P. McCarthy,et al. Atrial fibrillation in patients with coronary disease , 2007, Journal of Interventional Cardiac Electrophysiology.
[29] M. Franz,et al. Risk of Stroke in Patients With Atrial Flutter , 2001 .
[30] A. Capucci,et al. Dronedarone for prevention of atrial fibrillation: a dose-ranging study. , 2003, European heart journal.
[31] K. Arakawa,et al. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. , 2003, Journal of the American College of Cardiology.
[32] W. Abelmann,et al. PATIENTS WITH MITRAL STENOSIS AND SYSTEMIC EMBOLI; HEMODYNAMIC AND CLINICAL OBSERVATIONS. , 1964, Archives of internal medicine.
[33] M. Hocini,et al. Effect of catheter ablation on quality of life of patients with paroxysmal atrial fibrillation. , 2005, Heart rhythm.
[34] D. Levy,et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.
[35] N. Samani,et al. The effect of preoperative atrial fibrillation on survival following mitral valve repair for degenerative mitral regurgitation. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[36] S. Lévy. Do we need pharmacological therapy for atrial fibrillation in the ablation era? , 2007, Journal of Interventional Cardiac Electrophysiology.
[37] C. Hamm,et al. Usefulness of Atrial Fibrillation Burden as a Predictor for Success of Pulmonary Vein Isolation , 2005, Pacing and clinical electrophysiology : PACE.
[38] KikuoArakawa,et al. Angiotensin II Antagonist Prevents Electrical Remodeling in Atrial Fibrillation , 2000 .
[39] Y. Blaauw,et al. Atrial fibrillation: insights from clinical trials and novel treatment options , 2007, Journal of internal medicine.
[40] S. Asirvatham. Pulmonary vein-related maneuvers: part I. , 2007, Heart rhythm.
[41] A. Sheikhzadeh,et al. Detection of a Hypercoagulable State in Nonvalvular Atrial Fibrillation and the Effect of Anticoagulant Therapy , 1996, Thrombosis and Haemostasis.
[42] O. Alfieri,et al. Atrial Electroanatomic Remodeling After Circumferential Radiofrequency Pulmonary Vein Ablation: Efficacy of an Anatomic Approach in a Large Cohort of Patients With Atrial Fibrillation , 2001, Circulation.
[43] Yuchiao Chang,et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. , 2003, The New England journal of medicine.
[44] M. Enriquez-Sarano,et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. , 2002, Journal of the American College of Cardiology.
[45] V. Somers,et al. Atrial fibrillation and obesity--results of a meta-analysis. , 2008, American heart journal.
[46] J. Macgregor,et al. The effects of rate and irregularity on sympathetic nerve activity in human subjects. , 2007, Heart rhythm.
[47] D. Packer,et al. Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation , 2008, Journal of Interventional Cardiac Electrophysiology.
[48] A. Nogami,et al. Segmental pulmonary vein isolation for paroxysmal atrial fibrillation improves quality of life and clinical outcomes. , 2003, Circulation journal : official journal of the Japanese Circulation Society.
[49] T. Arentz,et al. Incidence of pulmonary vein stenosis 2 years after radiofrequency catheter ablation of refractory atrial fibrillation. , 2003, European heart journal.
[50] A L Waldo,et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.
[51] D. Mehta,et al. Thromboembolism following cardioversion of "common" atrial flutter. Risk factors and limitations of transesophageal echocardiography. , 1996, Chest.
[52] C. Hamm,et al. Asymptomatic recurrences of atrial fibrillation after pulmonary vein isolation. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[53] T. Asano,et al. Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation. , 2007, Journal of cardiology.
[54] Stroke Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study , 1994, The Lancet.
[55] F. Morady,et al. Prevalence of Asymptomatic Recurrences of Atrial Fibrillation After Successful Radiofrequency Catheter Ablation , 2004, Journal of cardiovascular electrophysiology.
[56] R. Page,et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. , 1994, Circulation.
[57] EmileDaoud,et al. Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation , 2008 .
[58] P. Wolf,et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.
[59] S. Mouly,et al. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. , 2007, The Cochrane database of systematic reviews.
[60] M. Chung,et al. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. , 2005, American heart journal.
[61] G. Lip,et al. Tedisamil: a new novel antiarrhythmic , 2004, Expert Opinion on Investigational Drugs.
[62] E. Mascha,et al. Effect of dexamethasone on atrial fibrillation after cardiac surgery: prospective, randomized, double-blind, placebo-controlled trial. , 2007, Journal of cardiothoracic and vascular anesthesia.
[63] J. Ruskin,et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. , 2007, Heart rhythm.
[64] S. Hohnloser,et al. Rhythm or rate control in atrial fibrillation-pharmacological intervention in atrial fibrillation (PIAF): a randomised trial , 2001 .
[65] P. Tchou,et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. , 2002, Journal of the American College of Cardiology.
[66] Sonia S Anand,et al. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. , 1999, JAMA.
[67] R. Hart,et al. Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 2000 .
[68] B. Horne,et al. Frequency of elevation of C-reactive protein in atrial fibrillation. , 2004, The American journal of cardiology.
[69] M. Coceani,et al. Catheter Ablation of Long‐Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias , 2006, Journal of cardiovascular electrophysiology.
[70] Bartley P Griffith,et al. Predictors and impact of atrial fibrillation after isolated coronary artery bypass grafting , 2002, Critical care medicine.
[71] O. Alfieri,et al. Atrio-Esophageal Fistula as a Complication of Percutaneous Transcatheter Ablation of Atrial Fibrillation , 2004, Circulation.
[72] G. Hutchins,et al. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. , 1994, Journal of the American College of Cardiology.
[73] J. Halperin,et al. "Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents. , 2008, Journal of the American College of Cardiology.
[74] Tong Liu,et al. Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies. , 2008, International journal of cardiology.
[75] L. Frost,et al. Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation. , 2000, The American journal of medicine.
[76] D. Packer,et al. Clinical Presentation, Investigation, and Management of Pulmonary Vein Stenosis Complicating Ablation for Atrial Fibrillation , 2005, Circulation.
[77] Jonathan H Seltzer,et al. The Diagnosis of Cardiac Arrhythmias: A Prospective Multi‐Center Randomized Study Comparing Mobile Cardiac Outpatient Telemetry Versus Standard Loop Event Monitoring , 2007, Journal of cardiovascular electrophysiology.
[78] J Clémenty,et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.
[79] M. Ezekowitz,et al. Alternate-day dosing of aspirin in atrial fibrillation: A critical evaluation. , 1999, American heart journal.
[80] N. Lakkis,et al. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. , 2007, Journal of the American College of Cardiology.
[81] I. Khan. Atrial stunning: determinants and cellular mechanisms. , 2003, American heart journal.
[82] P. Alboni,et al. Outpatient treatment of recent-onset atrial fibrillation with the “pill-in-the-pocket” approach , 2005 .
[83] Claus Schmitt,et al. Freedom From Atrial Tachyarrhythmias After Catheter Ablation of Atrial Fibrillation: A Randomized Comparison Between 2 Current Ablation Strategies , 2005, Circulation.
[84] Prashanthan Sanders,et al. Localized Sources Maintaining Atrial Fibrillation Organized by Prior Ablation , 2006, Circulation.
[85] Shih-AnnChen,et al. Alterations of Heart Rate Variability After Radiofrequency Catheter Ablation of Focal Atrial Fibrillation Originating From Pulmonary Veins , 1999 .
[86] M. P. van den Berg,et al. C-reactive protein and microalbuminuria are associated with atrial fibrillation. , 2005, International journal of cardiology.
[87] W. E. Kemp,et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation. , 1998, Circulation.
[88] M. Hennersdorf,et al. Prevalence of Paroxysmal Atrial Fibrillation Depending on the Regression of Left Ventricular Hypertrophy in Arterial Hypertension , 2007, Hypertension Research.
[89] A. Waldo. The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: Assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre st , 2007 .
[90] J. Svendsen,et al. Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: a randomized trial of the ostial versus the extraostial ablation strategy. , 2006, American heart journal.
[91] C. Otto,et al. Valvular aortic stenosis: disease severity and timing of intervention. , 2006, Journal of the American College of Cardiology.
[92] A Laupacis,et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. , 1995, Archives of internal medicine.
[93] Yuchiao Chang,et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.
[94] T. W. Mattingly,et al. Systemic arterial embolism in rheumatic heart disease. , 1951, American heart journal.
[95] T. Kural,et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. , 1996, The American journal of cardiology.
[96] H. Nakagawa,et al. Electrical Stimulation to Identify Neural Elements on the Heart: Their Role in Atrial Fibrillation , 2005, Journal of Interventional Cardiac Electrophysiology.
[97] H. Oral,et al. Postoperative atrial fibrillation. , 2009, Cardiology clinics.
[98] K. Yokoyama,et al. Localization of left atrial autonomic ganglionated plexuses using endocardial and epicardial high frequency stimulation in patients with atrial fibrillation , 2005 .
[99] Douglas L Packer,et al. Progress in Nonpharmacologic Therapy of Atrial Fibrillation , 2003, Journal of cardiovascular electrophysiology.
[100] B. Gersh,et al. The Natural History of Lone Atrial Flutter , 2004, Annals of Internal Medicine.
[101] W. Manning,et al. Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. , 1995, The American journal of cardiology.
[102] M. Eliasziw,et al. Occurrence of Hemispheric and Retinal Ischemia in Atrial Fibrillation Compared With Carotid Stenosis , 2002, Stroke.
[103] M. Di leo,et al. Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation. , 1999, The American journal of cardiology.
[104] V. Santinelli,et al. A randomized study of prophylactic catheter ablation in asymptomatic patients with the wolff-parkinson-white syndrome , 2004 .
[105] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[106] D. Lappé,et al. Temporary esophageal stenting allows healing of esophageal perforations following atrial fibrillation ablation procedures. , 2005, Journal of cardiovascular electrophysiology.
[107] R Lazzara,et al. Catheter Ablation of Cardiac Autonomic Nerves for Prevention of Vagal Atrial Fibrillation , 2000, Circulation.
[108] U. Tebbe,et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. , 2003, Journal of the American College of Cardiology.
[109] C. Tai,et al. Alterations of heart rate variability after radiofrequency catheter ablation of focal atrial fibrillation originating from pulmonary veins. , 1999, Circulation.
[110] J. Franklyn,et al. Association between serum free thyroxine concentration and atrial fibrillation. , 2007, Archives of internal medicine.
[111] E. Ellerbeck,et al. Combined Anticoagulant–Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients , 2004, Stroke.
[112] W. Rogers,et al. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.
[113] R. Hart. Stroke prevention in atrial fibrillation , 2000, Current cardiology reports.
[114] J. Auer,et al. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. , 2001, American heart journal.
[115] P. Howard,et al. Potential Use of Statins to Prevent Atrial Fibrillation After Coronary Artery Bypass Surgery , 2008, The Annals of pharmacotherapy.
[116] F. Morady,et al. Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation. , 1996, The American journal of cardiology.
[117] Jeremy N Ruskin,et al. Three‐Dimensional Analysis of Pulmonary Venous Ostial and Antral Anatomy: Implications for Balloon Catheter‐Based Pulmonary Vein Isolation , 2006, Journal of cardiovascular electrophysiology.
[118] B. Gersh,et al. Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation: A 30-Year Follow-Up Study , 2007, Circulation.
[119] J Clémenty,et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. , 1997, Circulation.
[120] Ralph B. D'Agostino,et al. Parental Atrial Fibrillation as a Risk Factor for Atrial Fibrillation in Offspring , 2004 .
[121] Martha J. Radford,et al. Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .
[122] D. Fatkin,et al. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. , 1994, Journal of the American College of Cardiology.
[123] E L Pritchett,et al. Observations on the transition from intermittent to permanent atrial fibrillation. , 2000, American heart journal.
[124] M. Horlitz,et al. Atrio-oesophageal fistula following circumferential pulmonary vein ablation: verification of diagnosis with multislice computed tomography. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[125] M. Mansour,et al. Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. , 2002, Cardiovascular research.
[126] V. Santinelli,et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. , 2006, Journal of the American College of Cardiology.
[127] A. Terzic,et al. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation , 2007, Nature Clinical Practice Cardiovascular Medicine.
[128] G. Lip,et al. Atrial fibrillation and stroke prevention , 2007, The Lancet Neurology.
[129] M. Allessie,et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.
[130] J Clémenty,et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. , 2000, Circulation.
[131] F. Morady,et al. Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial Fibrillation , 2006, Circulation.
[132] S. Hohnloser,et al. Drug therapy , 2022 .
[133] G. Boriani,et al. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long‐term outcome , 2007, International journal of clinical practice.
[134] R. Page,et al. Effect of Atrial Fibrillation and an Irregular Ventricular Response on Sympathetic Nerve Activity in Human Subjects , 2003, Circulation.
[135] Douglas Packer,et al. Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation.
[136] L. Kuller,et al. Alcohol consumption and risk and prognosis of atrial fibrillation among older adults: the Cardiovascular Health Study. , 2007, American heart journal.
[137] D. Shah,et al. Catheter Ablation of Chronic Atrial Fibrillation Targeting the Reinitiating Triggers , 2000, Journal of cardiovascular electrophysiology.
[138] L. Poller,et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. , 1993, The New England journal of medicine.
[139] R. Page,et al. Asymptomatic atrial fibrillation. , 2005, Progress in cardiovascular diseases.
[140] M. Nakagawa,et al. Fibrinopeptide A (FPA) levels in atrial fibrillation and the effects of heparin administration. , 1988, Japanese circulation journal.
[141] R. Roberts. Mechanisms of Disease: genetic mechanisms of atrial fibrillation , 2006, Nature Clinical Practice Cardiovascular Medicine.
[142] J. Gore,et al. Magnitude of and Risk Factors for In-Hospital and Postdischarge Stroke in Patients With Acute Coronary Syndromes: Findings From a Global Registry of Acute Coronary Events , 2005, Circulation.
[143] S. Mouly,et al. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. , 2006, Archives of internal medicine.
[144] F. Gaita,et al. Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications , 2007, Journal of cardiovascular medicine.
[145] Bernard Rosner,et al. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1990, The New England journal of medicine.
[146] C. Tracy,et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, European heart journal.
[147] C. Tai,et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. , 1999, Circulation.
[148] Cynthia A. Carnes,et al. C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation , 2001, Circulation.
[149] J. Ruskin,et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. , 2007, Heart rhythm.
[150] E. Sosa,et al. Left Atrial‐Esophageal Fistula Complicating Radiofrequency Catheter Ablation of Atrial Fibrillation , 2005, Journal of cardiovascular electrophysiology.
[151] D. Levy,et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. , 2004, The American journal of cardiology.
[152] M A Waclawiw,et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. , 1998, Journal of the American College of Cardiology.
[153] J. Molnar,et al. Prevention of Atrial Fibrillation by Way of Abrogation of the Renin-Angiotensin System: A Systematic Review and Meta-Analysis , 2008, American journal of therapeutics.
[154] Bruce M Psaty,et al. Inflammation as a Risk Factor for Atrial Fibrillation , 2003, Circulation.
[155] W. Decker,et al. Management of atrial fibrillation in the emergency department. , 2005, Emergency medicine clinics of North America.
[156] A. Massumi,et al. Stroke prevention in nonvalvular atrial fibrillation. , 2011, Texas Heart Institute journal.
[157] K. Nademanee,et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. , 2004, Journal of the American College of Cardiology.
[158] StanleyNattel,et al. Omega-3 Polyunsaturated Fatty Acids Prevent Atrial Fibrillation Associated With Heart Failure but Not Atrial Tachycardia Remodeling , 2007 .
[159] W. Rheinboldt,et al. A COMPUTER MODEL OF ATRIAL FIBRILLATION. , 1964, American heart journal.
[160] S M Nazarian,et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.
[161] V. Barriales,et al. Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group. , 1999, American heart journal.
[162] S. Asirvatham. Pacing maneuvers for nonpulmonary vein sources: part II. , 2007, Heart rhythm.
[163] W. Saliba,et al. Brief Communication: AtrialEsophageal Fistulas after Radiofrequency Ablation , 2006, Annals of Internal Medicine.
[164] C. Israel,et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. , 2004, Journal of the American College of Cardiology.
[165] O. Orning,et al. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. , 1969, The American journal of cardiology.
[166] P. Box. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery:A randomized controlled trial , 2007 .
[167] Antonio De Simone,et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). , 2006, European heart journal.
[168] C. White,et al. Dronedarone: An Amiodarone Analog for the Treatment of Atrial Fibrillation and Atrial Flutter , 2007, The Annals of pharmacotherapy.
[169] Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2002 .
[170] Gregory Y H Lip,et al. Quality of life in patients with atrial fibrillation: a systematic review. , 2006, The American journal of medicine.
[171] Xu-Fang Yu. Association of atrial fibrillation and obstructive sleep apnea , 2011 .
[172] S. Hohnloser,et al. Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter. , 2004, Journal of the American College of Cardiology.
[173] A. Keech,et al. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. , 2006, European heart journal.